CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0316

IGF-1 LR3

Filed under Peptides. The bureau holds 245 laboratory returns for this compound from 100 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

100 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760 A 6 10.0 9.9 10.0 23 May 2026 23 May 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 4 10.0 9.9 10.0 26 Nov 2025 23 Jun 2026
AmbioPharmCASE #VI-2026-0177 A 4 10.0 9.9 10.0 13 Jun 2026 23 Jul 2026
Sangon BioCASE #VI-2026-0671 A 3 10.0 10.0 10.0 13 Jun 2026 4 Jul 2026
Kerui PeptidesCASE #VI-2026-0626 A 3 10.0 9.9 10.0 21 Mar 2026 11 Jul 2026
GenScript PeptidesCASE #VI-2026-0860 A 3 10.0 10.0 10.0 14 Apr 2026 7 Aug 2026
PolyPeptide GroupCASE #VI-2026-0143 A 3 10.0 10.0 10.0 5 Apr 2026 6 Aug 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 3 10.0 10.0 10.0 4 Jul 2026 17 Aug 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 2 10.0 10.0 10.0 20 May 2026 16 Jun 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 2 10.0 10.0 10.0 2 Nov 2025 1 Jun 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 2 10.0 10.0 10.0 5 Apr 2026 9 Apr 2026
Aavant ResearchCASE #VI-2026-0831 X 1 10.0 10.0 10.0 6 May 2025 6 May 2025
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 7 9.9 9.9 10.0 14 Nov 2025 16 Apr 2026
QYAOBIOCASE #VI-2026-0861 A 4 9.9 9.9 10.0 16 Dec 2025 19 May 2026
BachemCASE #VI-2026-0314 A 4 9.9 9.9 10.0 2 Apr 2026 12 Jul 2026
WuXi TIDESCASE #VI-2026-0335 A 4 9.9 9.9 10.0 13 Jan 2026 11 Jun 2026
Sigma-AldrichCASE #VI-2026-0829 A 4 9.9 9.9 10.0 2 Mar 2026 20 May 2026
JEEP PeptidesCASE #VI-2026-0457 A 3 9.9 9.9 10.0 8 May 2026 11 Jun 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 3 9.9 9.9 10.0 4 May 2026 12 Jul 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 3 9.9 9.9 10.0 25 May 2026 4 Jul 2026
AsymchemCASE #VI-2026-0091 A 3 9.9 9.9 10.0 22 May 2026 15 Aug 2026
Hubei JianxiangCASE #VI-2026-0048 A 2 9.9 9.9 10.0 24 Mar 2026 3 Jul 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 2 9.9 9.9 9.9 22 Jan 2026 6 May 2026
SinoPepCASE #VI-2026-0387 A 2 9.9 9.9 10.0 5 Aug 2026 11 Aug 2026
Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 X 1 9.9 9.9 9.9 28 Mar 2025 28 Mar 2025
Orbitrex PeptidesCASE #VI-2026-0812 X 1 9.7 9.7 9.7 8 Jul 2025 8 Jul 2025
Diju Peptides Wellness and CoCASE #VI-2026-0724 X 1 9.5 9.5 9.5 28 Mar 2025 28 Mar 2025
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 5 9.4 7.6 10.0 21 May 2026 21 May 2026
Precision Peptide CoCASE #VI-2026-0559 X 1 9.4 9.4 9.4 11 Jun 2025 11 Jun 2025
Lisa BiopeptideCASE #VI-2026-0131 X 1 9.4 9.4 9.4 11 Jun 2025 11 Jun 2025
The Naughty NeedleCASE #VI-2026-0432 X 1 9.3 9.3 9.3 27 Feb 2025 27 Feb 2025
Bulk Peptide SupplyCASE #VI-2026-0446 X 1 9.3 9.3 9.3 7 May 2025 7 May 2025
Trusted PeptideCASE #VI-2026-0499 X 1 9.2 9.2 9.2 11 Jun 2025 11 Jun 2025
Huaian Hanyou PeptideCASE #VI-2026-0297 X 1 9.0 9.0 9.0 3 Jun 2025 3 Jun 2025
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 2 8.9 8.4 9.5 24 May 2026 24 May 2026
Rayshine Peptide BiochemicalsCASE #VI-2026-0545 X 1 8.8 8.8 8.8 21 May 2025 21 May 2025
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 6 8.5 7.2 8.8 21 May 2026 21 May 2026
BfflinkCASE #VI-2026-0212 X 1 8.5 8.5 8.5 3 Jul 2025 3 Jul 2025
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 3 8.4 6.8 10.0 23 May 2026 23 May 2026
Golden EagleCASE #VI-2026-0680 X 1 8.2 8.2 8.2 28 Mar 2025 28 Mar 2025
TCICASE #VI-2026-0650 X 1 8.1 8.1 8.1 2 Jul 2025 2 Jul 2025
Glbiochem (Shanghai)CASE #VI-2026-0704 A 5 8.0 6.2 9.6 24 May 2026 24 May 2026
LipeptidesCASE #VI-2026-0863 X 1 8.0 8.0 8.0 25 Apr 2025 25 Apr 2025
Peptide-SCASE #VI-2026-0111 X 8 7.8 6.5 8.6 21 May 2025 24 May 2026
Xianhong Tong XHT PeptidesCASE #VI-2026-0997 X 1 7.7 7.7 7.7 6 May 2025 6 May 2025
Polaris PeptidesCASE #VI-2026-0839 X 8 7.5 6.3 10.0 28 Mar 2025 26 Jan 2026
Eros PeptidesCASE #VI-2026-0918 X 1 7.5 7.5 7.5 13 Feb 2025 13 Feb 2025
Prime PeptidesCASE #VI-2026-0696 X 1 7.5 7.5 7.5 17 Dec 2024 17 Dec 2024
Kits4lessCASE #VI-2026-0744 X 1 7.4 7.4 7.4 3 Jun 2025 3 Jun 2025
Skye PeptidesCASE #VI-2026-0451 X 6 7.3 4.6 9.1 25 Apr 2025 23 May 2026
Planet PeptideCASE #VI-2026-0092 X 4 7.3 5.8 8.4 2 Jul 2025 21 May 2026
UWA Elite PeptidesCASE #VI-2026-0130 X 1 7.3 7.3 7.3 16 Mar 2025 16 Mar 2025
Bulk Peptide WholesaleCASE #VI-2026-0319 A 2 7.2 7.2 7.3 20 Jun 2025 21 May 2026
ZLZ PeptideCASE #VI-2026-0524 X 12 7.0 3.2 9.3 9 Jun 2025 25 May 2026
Yiwu Aozuo Trading CoCASE #VI-2026-0798 X 8 7.0 5.7 9.6 2 Jul 2025 24 May 2026
LSPLCASE #VI-2026-0523 X 2 6.9 5.5 8.3 24 Apr 2025 21 May 2026
Lux Synth AminosCASE #VI-2026-0700 X 1 6.9 6.9 6.9 20 Jun 2025 20 Jun 2025
Qing Li PeptideCASE #VI-2026-0469 X 14 6.8 4.6 10.0 9 Jun 2025 20 May 2026
Swiss ChemsCASE #VI-2026-0030 X 1 6.7 6.7 6.7 7 May 2025 7 May 2025
ZZQ PeptidesCASE #VI-2026-0550 X 1 6.7 6.7 6.7 9 Jun 2025 9 Jun 2025
HXNetCASE #VI-2026-0061 X 3 6.6 6.2 7.1 11 Jun 2025 17 May 2026
Paramount PeptidesCASE #VI-2026-0550 X 6 6.5 4.4 9.1 3 Jul 2025 25 May 2026
Quenna PMQCASE #VI-2026-0415 X 1 6.3 6.3 6.3 16 Mar 2025 16 Mar 2025
Biolongevity LabsCASE #VI-2026-0442 X 2 6.2 5.7 6.6 6 May 2025 26 Jan 2026
BeiBangAnCASE #VI-2026-0899 X 2 6.2 5.1 7.2 3 Jun 2025 26 Jan 2026
Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 X 1 6.2 6.2 6.2 6 May 2025 6 May 2025
Peptide WorldwideCASE #VI-2026-0217 X 1 6.1 6.1 6.1 3 Jul 2025 3 Jul 2025
Amino LairCASE #VI-2026-0413 X 1 6.1 6.1 6.1 11 Jun 2025 11 Jun 2025
Hebei Rimao TechnologyCASE #VI-2026-0529 X 3 6.0 4.8 8.1 16 Mar 2025 26 Jan 2026
NextechLabsCASE #VI-2026-0285 X 2 6.0 5.4 6.6 25 Apr 2025 21 May 2026
Liberty PeptidesCASE #VI-2026-0416 X 1 6.0 6.0 6.0 3 Jul 2025 3 Jul 2025
HazelCASE #VI-2026-0392 X 1 6.0 6.0 6.0 24 Apr 2025 24 Apr 2025
HkRoidsCASE #VI-2026-0784 X 1 6.0 6.0 6.0 13 Jun 2025 13 Jun 2025
LN PeptidesCASE #VI-2026-0781 X 1 5.9 5.9 5.9 3 Jun 2025 3 Jun 2025
CellupepCASE #VI-2026-0888 X 1 5.8 5.8 5.8 14 Jan 2025 14 Jan 2025
Laicuinuo LCNCASE #VI-2026-0223 X 1 5.8 5.8 5.8 14 Jan 2025 14 Jan 2025
Anlv BiotechnologyCASE #VI-2026-0110 X 1 5.7 5.7 5.7 2 Jul 2025 2 Jul 2025
Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 X 1 5.7 5.7 5.7 28 Mar 2025 28 Mar 2025
Astro PeptidesCASE #VI-2026-0424 X 2 5.6 5.0 6.2 16 Mar 2025 20 May 2026
Xian Yihang TechnologyCASE #VI-2026-0656 X 2 5.5 4.4 6.5 3 Jul 2025 20 May 2026
PurePEPSCASE #VI-2026-0552 X 1 5.5 5.5 5.5 3 Jul 2025 3 Jul 2025
Wolverine PeptidesCASE #VI-2026-0262 X 1 5.4 5.4 5.4 16 Mar 2025 16 Mar 2025
Peptides 4 ResearchCASE #VI-2026-0511 X 2 5.2 4.2 6.2 14 Jan 2025 19 Jan 2026
Eternal PeptidesCASE #VI-2026-0842 X 1 5.2 5.2 5.2 2 Apr 2025 2 Apr 2025
Shaanxi Dideu MedichemCASE #VI-2026-0499 X 1 5.2 5.2 5.2 16 Mar 2025 16 Mar 2025
Richards Biotech Simply RichardsCASE #VI-2026-0307 X 1 5.1 5.1 5.1 3 Jul 2025 3 Jul 2025
Zztai PeptideCASE #VI-2026-0192 C 3 4.9 2.2 6.5 25 Apr 2025 24 May 2026
Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 X 1 4.1 4.1 4.1 24 Apr 2025 24 Apr 2025
Biolabshop LimitedCASE #VI-2026-0832 X 1 4.0 4.0 4.0 2 Apr 2025 2 Apr 2025
Regenerative ResearchCASE #VI-2026-0349 X 1 3.9 3.9 3.9 2 Apr 2025 2 Apr 2025
DeuschemCASE #VI-2026-0004 X 1 3.9 3.9 3.9 13 Jun 2025 13 Jun 2025
Peptide GurusCASE #VI-2026-0854 X 4 3.5 2.5 4.8 27 Feb 2025 26 Jan 2026
Forever Young PharmacyCASE #VI-2026-0654 X 1 3.2 3.2 3.2 21 May 2025 21 May 2025
Peptides For SaleCASE #VI-2026-0614 X 2 2.4 2.3 2.5 21 May 2025 21 May 2026
Pharma Grade PeptidesCASE #VI-2026-0208 X 1 1.5 1.5 1.5 13 Feb 2025 13 Feb 2025
Weifang Xingbei International TradeCASE #VI-2026-0766 X 1 0.5 0.5 0.5 9 Jun 2025 9 Jun 2025
PRIVATECASE #VI-2026-0635 X 1 0.2 0.2 0.2 17 Dec 2024 17 Dec 2024
PepLab SolutionsCASE #VI-2026-0431 X 1 0.0 0.0 0.0 7 May 2025 7 May 2025
NuLife PeptidesCASE #VI-2026-0980 X 1 0.0 0.0 0.0 13 Feb 2025 13 Feb 2025
Coffee and PeppersCASE #VI-2026-0274 X 1 0.0 0.0 0.0 14 Jan 2025 14 Jan 2025

Open any subject to view the batch-level evidence for IGF-1 LR3 alone.